Insulin Autoimmune Syndrome: A Chinese Expert Consensus Statement.

Area of Science:

• Endocrinology
• Immunology
• Metabolic Disorders

Background:

• Insulin autoimmune syndrome (IAS) is a rare autoimmune disorder causing spontaneous hypoglycemia.
• IAS incidence is notably higher in East Asian populations.
• Delayed diagnosis and treatment of IAS can lead to severe glucose fluctuations and life-threatening complications.

Purpose of the Study:

• To systematically summarize the epidemiology, triggers, pathogenesis, and clinical features of IAS.
• To outline diagnostic and differential diagnostic approaches for IAS.
• To establish standardized recommendations for the clinical management and prognosis of IAS.

Main Methods:

• Systematic review of existing literature on IAS.
• Consensus-based approach for guideline development.
• Synthesis of data on epidemiology, clinical presentation, diagnosis, and treatment.

Main Results:

• Detailed summary of IAS epidemiology, with emphasis on higher incidence in East Asian populations.
• Comprehensive overview of IAS triggers, pathogenesis, and clinical manifestations.
• Evidence-based recommendations for diagnosis, differential diagnosis, and treatment strategies.

Conclusions:

• Standardized guidelines are crucial for the timely and accurate diagnosis and management of IAS.
• This consensus aims to reduce adverse clinical outcomes associated with IAS by providing a unified approach.
• Improved management of IAS can mitigate risks of recurrent hypoglycemia and improve patient prognosis.